You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH)擬與上善投資等共設康健投資基金
格隆匯 10-12 17:26

格隆匯 10 月 12日丨方盛製藥(603998.SH)公佈,公司決定與深圳前海上善金石投資管理有限公司(“上善投資”)、湖南高新創投健康養老基金管理有限公司(“高新創投”)、長沙市長信投資管理公司(“長信投資”)、長沙高新開發區麓谷創業服務有限公司(“高新創服”)、長沙鬥邦企業管理諮詢合夥企業(有限合夥)(“鬥邦諮詢”)、湖南健康養老產業投資基金企業(有限合夥)(“養老基金”)共同出資設立長沙星辰康健投資合夥企業(有限合夥)(暫定名,以工商登記核准為準,“康健投資基金”)。

該康健投資基金總規模為3.75億元,其中,公司作為有限合夥人,以自有資金出資1.125億元人民幣,佔總規模的30%。公司已與上述其他合夥人就此次設立康健投資基金事項簽署了《合夥協議》。

通過與上善投資及區域內國資背景的專業投資機構合作設立康健投資基金,公司可以藉助專業投資機構在生物醫藥與健康行業上下游的資源及資金募集渠道和專業投資判斷能力,一方面可以為公司尋找投資機會,通過投資優質標的獲得較好的財務投資回報;另一方面也有助於公司尋找優質的投資標的,為公司在生物醫藥與健康行業的產業整合提供支持,實現資本與產業的有機結合,為公司通過外延式擴張的方式快速做大做強提供支持,而且前期通過康健投資基金對公司看好的擬投資的標的企業進行培育,可以降低公司直接投資帶來的風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account